L. Zhang, Z. Zhang, Y. Lu, J. Zhang, and V. R. Preedy,

L. Tea, Transport and Effects on Health, Tea in Health and Disease Prevention, vol.35, p.435

L. R. Juneja, D. Chu, T. Okubo, Y. Nagato, Y. et al.,

, L-theanine?a unique amino acid of green tea and its relaxation effect in humans, Trends Food Sci. Technol, vol.10

D. J. White, S. De-klerk, W. Woods, S. Gondalia, C. Noonan et al., Anti-Stress, Behavioural and Magnetoencepha-J lography Effects of an l-Theanine-Based Nutrient Drink: A Randomised, Double-Blind, Placebo-Controlled, Crossover Trial. Nutrients, vol.8, p.53, 2016.

S. Hidese, M. Ota, C. Wakabayashi, T. Noda, H. Ozawa et al., Effects of chronic l-theanine administration in patients with major depressive disorder: an open-label study, Acta Neuropsychiatr, vol.29, p.72, 2017.

T. I. Kim, Y. K. Lee, S. G. Park, I. S. Choi, J. O. Ban et al., ) lTheanine, an amino acid in green tea, attenuates beta-amyloid-induced cognitive dysfunction and neurotoxicity: reduction in oxidative damage and inactivation of ERK/p38 kinase and NF-kappaB pathways, Free Radical Biol. Med, vol.47, pp.1601-1610, 2009.

N. Egashira, K. Hayakawa, M. Osajima, K. Mishima, K. Iwasaki et al., Involvement of GABA(A) receptors in the neuroprotective effect of theanine on focal cerebral ischemia in mice, J. Pharmacol. Sci, vol.105, pp.211-214, 2007.

T. Kakuda, Neuroprotective Effects of the Green Tea Components Theanine and Catechins, Biol. Pharm. Bull, vol.25, pp.1513-1518, 2002.

T. Kakuda, Neuroprotective effects of theanine and its preventive effects on cognitive dysfunction, Pharmacol. Res, vol.64, pp.162-168, 2011.

T. Kakuda, A. Nozawa, A. Sugimoto, and H. Niino, Inhibition by theanine of binding of, 2002.

, 519 to glutamate receptors, MDL 105, vol.66, pp.2683-2686

K. Nagasawa, H. Aoki, E. Yasuda, K. Nagai, S. Shimohama et al., Possible involvement of group I mGluRs in neuroprotective effect of theanine, Biochem. Biophys. Res. Commun, vol.320, pp.116-122, 2004.

X. Di, J. Yan, Y. Zhao, J. Zhang, Z. Shi et al., L-theanine protects the APP (Swedish mutation) transgenic SH-SY5Y cell against glutamate-induced excitotoxicity via inhibition of the NMDA receptor pathway, Neuroscience, vol.168, pp.778-786, 2010.

T. Kakuda, H. Yanase, K. Utsunomiya, A. Nozawa, T. Unno et al., Protective effect of gamma-glutamylethylamide (theanine) on ischemic delayed neuronal death in gerbils, Neurosci. Lett, vol.289, pp.189-192, 2000.

T. Yamada, T. Terashima, S. Kawano, R. Furuno, T. Okubo et al., Theanine, gammaglutamylethylamide, a unique amino acid in tea leaves, modulates neurotransmitter concentrations in the brain striatum interstitium in conscious rats, Amino Acids, vol.36, pp.21-27, 2009.

C. Wakabayashi, T. Numakawa, M. Ninomiya, S. Chiba, and H. Kunugi, Behavioral and molecular evidence for psychotropic effects in L-theanine, Psychopharmacology (Berl.), vol.219, pp.1099-1109, 2012.

J. T. Coyle, NMDA receptor and schizophrenia: a brief history, Schizophr. Bull, vol.38, pp.920-926, 2012.

S. Schade and W. Paulus, D-Cycloserine in Neuropsychiatric Diseases: A Systematic Review, Int. J. Neuropsychopharmacol, vol.19, p.102, 2016.

A. Volianskis, G. France, M. S. Jensen, Z. A. Bortolotto, D. E. Jane et al., Long-term potentiation and the role of N-methyl-D-aspartate receptors, Brain Res, vol.1621, pp.5-16, 2015.

G. L. Collingridge, S. Peineau, J. G. Howland, and Y. T. Wang, Long-term depression in the CNS, Nat. Rev. Neurosci, vol.11, pp.459-473, 2010.

P. Steullet, J. H. Cabungcal, A. Monin, D. Dwir, P. O'donnell et al., Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A "central hub" in schizophrenia pathophysiology?, Schizophr. Res, vol.176, pp.41-51, 2016.

M. Escobar, N. Crouzin, M. Cavalier, J. Quentin, J. Roussel et al., Early, timedependent disturbances of hippocampal synaptic transmission and plasticity after in utero immune challenge, Biol. Psychiatry, vol.70, pp.992-999, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00574559

M. Vignes, Regulation of spontaneous inhibitory synaptic transmission by endogenous glutamate via non-NMDA receptors in cultured rat hippocampal neurons, Neuropharmacology, vol.40, pp.737-748, 2001.
URL : https://hal.archives-ouvertes.fr/hal-00659420

A. Takeda, H. Tamano, M. Suzuki, K. Sakamoto, N. Oku et al., Unique induction of CA1 LTP components after intake of theanine, an amino acid in tea leaves and its effect on stress response, Cell. Mol. Neurobiol, vol.32, pp.41-48, 2012.

H. Tamano, K. Fukura, M. Suzuki, K. Sakamoto, H. Yokogoshi et al., Advantageous effect of theanine intake on cognition, Nutr. Neurosci, vol.17, pp.279-283, 2014.

S. X. Baudouin, Process for purifying theanine. US Patent US7303773B2, 2008.

A. Ekanayake and J. J. Li, Process for enriching extracts of natural theanine, 2003.

F. Zhang, Q. Zheng, Q. Jiao, J. Liu, and G. Zhao,

, Enzymatic synthesis of theanine from glutamic acid ?-methyl ester and ethylamine by immobilized Escherichia coli cells with ?-glutamyltranspeptidase activity, Amino Acids, vol.39, pp.1177-1182

C. O. Kappe and A. Stadler, Microwaves in Organic and Medicinal Chemistry, 2005.

S. Zhu and P. Paoletti, Allosteric modulators of NMDA receptors: multiple sites and mechanisms, Curr. Opin. Pharmacol, vol.20, pp.14-23, 2015.

J. Burgdorf, X. Zhang, C. Weiss, E. Matthews, J. F. Disterhoft et al., The N-methyl-D-aspartate receptor modulator GLYX-13 enhances learning and memory, in young adult and learning impaired aging rats, Neurobiol. Aging, vol.32, pp.698-706, 2011.

J. Burgdorf, X. Zhang, K. L. Nicholson, R. L. Balster, J. D. Leander et al., GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects, Neuropsychopharmacology, vol.38, pp.729-742, 2013.

C. A. Jones, D. J. Watson, and K. C. Fone, Animal models of schizophrenia, Br. J. Pharmacol, vol.164, pp.1162-1194, 2011.

M. Ota, C. Wakabayashi, J. Matsuo, Y. Kinoshita, H. Hori et al., Effect of L-theanine on sensorimotor gating in healthy human subjects, Psychiatry Clin. Neurosci, vol.68, pp.337-343, 2014.

G. Clarke, S. O'mahony, G. Malone, and T. G. Dinan, An isocratic high performance liquid chromatography method for the determination of GABA and glutamate in discrete regions of the rodent brain, J. Neurosci. Methods, vol.160, pp.223-230, 2007.

E. M. Blanc, M. Jallageas, M. Recasens, and J. Guiramand, Potentiation of glutamatergic agonist-induced inositol phosphate formation by basic fibroblast growth factor is related to developmental features in hippocampal cultures: neuronal survival and glial cell proliferation, Eur. J. Neurosci, vol.11, pp.3377-3386, 1999.
URL : https://hal.archives-ouvertes.fr/hal-00397704

M. C. De-jesus-ferreira, N. Crouzin, G. Barbanel, C. Cohen-solal, M. Re?asens et al., A transient treatment of hippocampal neurons with alpha-tocopherol induces a long-lasting protection against oxidative damage via a genomic action, Free Radical Biol. Med, vol.39, issue.1009, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00397599

N. Crouzin, J. De, M. Ferreira, C. Cohen-solal, R. Aimar et al., Alpha-tocopherol-mediated long-lasting protection against oxidative damage involves an attenuation of calcium entry through TRP-like channels in cultured hippocampal neurons, Free Radical Biol. Med, vol.42, pp.1326-1337, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00397592